Neurogeneticists Use Personality Genes to Further Eugenics AgendaSusanne Posel, Contributor They even want to know how to proactively vaccinate the human population to discriminate against undesired genetic traits. At the Duke Neurogenetics department in Duke University Medical Center, undergraduate students are conducting experiments to gather information on people through brain scans, psychological tests and genetic markers. This study is led by Professor Ahmed Hariri, hopes to unlock the mysteries of a persons innate propensity toward anxiety, alcoholism, and other defining psychological traits. Through the decoding of human DNA, this just might be possible. Just over 10 years ago, Hariri and another team published a study at the National Institutes of Health that linked a particular gene to the inner workings of the human brain. Through the serotonin transport gene, Hariri was able to decipher the codes of a protein that assist in distributing serotonin to neurons. Hariri found most people carry either long or short versions of this gene. The short version intimated those people had a greater propensity toward anxiety disorders. Through Hariris work, nearly 30 studies have confirmed his findings, which have spawned more research into using genes to determine propensity toward depression, anxiety-related disorders and the genetics of psychological illnesses. Genes, if they affect our brains, as Hariri supposes, could be tweaked through pharmacological influence to produce a specific desired reaction. The drug corporations are currently developing pharmacological substitutes to block and break peoples addictive propensities as aids to psychological treatments. Vaccines to treat cocaine and nicotine addictions are being advanced in the hopes to use immunizations as proactive protection against the development of an addiction. There is even debate over whether or not to vaccinate children who show genetic propensity toward addictions. Benzodiazepine, an ethanol replacement in alcoholic drinks, could become a sober pill that could be offered in bars by 2030 to reduce the effects of alcohol on consumers. 23andMe, a California based corporation, examines a persons genome to identify natural propensities to diseases. Hariri hopes this company can link brain activity to genes, even if their influence is minimal. Hariri is searching for the brains reward regions that apply to genetic controls. He has had promising results with a brain enzyme called FAAH. Variation of this gene can alter a persons perception of reward and threat. The goal of these studies is to create a comprehensive genetic test for the mind. This test could help show how effective drugs like Prozac will affect an individuals propensity toward mental disorders like depression. Predetermination toward certain mental vulnerabilities can assist the psychiatric community in proactively prescribe pharmaceuticals to patients. Researchers can screen a patient, identify responsible genes and develop a drug that would target the undesirable mental disorder. Eugenicists of the past would be proud of Hariris efforts to advance their agenda of eliminating any traits they consider to be inferior in humanity for the advancement of our species. Susanne Posel is the Chief Editor of Occupy Corporatism. Our alternative news site is dedicated to reporting the news as it actually happens; not as it is spun by the corporately funded mainstream media. You can find us on ourFacebook page. linkwithin_text=Related Articles: 